Search alternatives:
"physician" » "physicians", "physical"

1
Published 2018
CADTH
... physician with experience in the diagnosis and management of GCA. A reduction in price...

2
Published 2018
CADTH
... is prescribed by a physician with experience in the diagnosis and management of hereditary tyrosinemia type-1...

3
Published 2014
Canadian Agency for Drugs and Technologies in Health
... for the clinical effectiveness of formal PA prescriptions issued by a physician or nurse practitioner...

4
Published 2014
Canadian Agency for Drugs and Technologies in Health
... for the clinical effectiveness of formal PA prescriptions issued by a physician or nurse practitioner...

5
Published 2018
CADTH
... physician with experience in the diagnosis and management of PD. Reduction in price...

6
Published 2018
CADTH
... physician with experience in the diagnosis and management of GCA. A reduction in price...

7
by Ho, Chuong, Adams, Alison
Published 2017
Canadian Agency for Drugs and Technologies in Health
... in healthcare settings such as physician offices, dental offices or emergent care settings. Despite...

8
Published 2019
Canadian Agency for Drugs and Technologies in Health
.... The diagnosis of HAE type I or II is made by a specialist physician who has experience in the diagnosis of HAE...

9
Published 2020
Canadian Agency for Drugs and Technologies in Health
... in patients with disease activity, based on the physician assessment...

10
Published 2018
CADTH
... is prescribed by a physician with experience in the diagnosis and management of hereditary tyrosinemia type-1...

11
by Ho, Chuong, Adams, Alison
Published 2017
Canadian Agency for Drugs and Technologies in Health
... in healthcare settings such as physician offices, dental offices or emergent care settings. Despite...

12
Published 2019
Canadian Agency for Drugs and Technologies in Health
.... The diagnosis of HAE type I or II is made by a specialist physician who has experience in the diagnosis of HAE...

13
Published 2017
CADTH
...) visits, or physician visits; a dearth of data for patients who fail treatment with a long-acting beta2...

14
Published 2018
Canadian Agency for Drugs and Technologies in Health
... in patients with an established diagnosis of HT-1. The drug is prescribed by a physician with experience...

15
Published 2018
CADTH
... physician with experience in the diagnosis and management of PD. Reduction in price...

16
Published 2018
CADTH
... physician with experience in the diagnosis and management of HCV infection. Drug plan cost for SOF/VEL/VOX...

17
Published 2017
CADTH
...) visits, or physician visits; a dearth of data for patients who fail treatment with a long-acting beta2...

18
Published 2020
Canadian Agency for Drugs and Technologies in Health
... in patients with disease activity, based on the physician assessment...

19
Published 2019
Canadian Agency for Drugs and Technologies in Health
... scale. 3. Severity of signs and symptoms of VKC should be documented by the treating physician...

20
Published 2013
Canadian Agency for Drugs and Technologies in Health
... is provided by a multidisciplinary team comprising of members such as physician, specialist, nurse, dietitian...